Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 636

    1.

    Final Version of 2009 AJCC Melanoma Staging and Classification.

    Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, McMasters KM, Mihm MC Jr, Morton DL, Ross MI, Sober AJ, Sondak VK.

    J Clin Oncol. 2009 Nov 16. [Epub ahead of print]PMID: 19917835 [PubMed - as supplied by publisher]Related articles

    2.

    Effect of granulocyte/macrophage colony-stimulating factor on vaccination with an allogeneic whole-cell melanoma vaccine.

    Faries MB, Hsueh EC, Ye X, Hoban M, Morton DL.

    Clin Cancer Res. 2009 Nov 15;15(22):7029-35. Epub 2009 Nov 10.PMID: 19903777 [PubMed - in process]Related articles

    3.

    Practice Patterns and Outcomes for Anorectal Melanoma in the USA, Reviewing Three Decades of Treatment: Is More Extensive Surgical Resection Beneficial in All Patients?

    Iddings DM, Fleisig AJ, Chen SL, Faries MB, Morton DL.

    Ann Surg Oncol. 2009 Sep 23. [Epub ahead of print]PMID: 19774417 [PubMed - as supplied by publisher]Related articles

    4.

    Reproducibility of placebo analgesia: Effect of dispositional optimism.

    Morton DL, Watson A, El-Deredy W, Jones AK.

    Pain. 2009 Nov;146(1-2):194-8. Epub 2009 Aug 18.PMID: 19692178 [PubMed - in process]Related articles

    5.

    Biological factors, tumor growth kinetics, and survival after metastasectomy for pulmonary melanoma.

    Lee JH, Gulec SA, Kyshtoobayeva A, Sim MS, Morton DL.

    Ann Surg Oncol. 2009 Oct;16(10):2834-9. Epub 2009 Jul 15.PMID: 19603235 [PubMed - in process]Related articles

    6.

    Aberrant Fatty Acid-Binding Protein-7 Gene Expression in Cutaneous Malignant Melanoma.

    Goto Y, Koyanagi K, Narita N, Kawakami Y, Takata M, Uchiyama A, Nguyen L, Nguyen T, Ye X, Morton DL, Hoon DS.

    J Invest Dermatol. 2009 Jul 9. [Epub ahead of print]PMID: 19587692 [PubMed - as supplied by publisher]Related articles

    7.

    Functional RET G691S polymorphism in cutaneous malignant melanoma.

    Narita N, Tanemura A, Murali R, Scolyer RA, Huang S, Arigami T, Yanagita S, Chong KK, Thompson JF, Morton DL, Hoon DS.

    Oncogene. 2009 Aug 27;28(34):3058-68. Epub 2009 Jun 29.PMID: 19561646 [PubMed - indexed for MEDLINE]Related articles

    8.

    Improved survival for stage IV melanoma from an unknown primary site.

    Lee CC, Faries MB, Wanek LA, Morton DL.

    J Clin Oncol. 2009 Jul 20;27(21):3489-95. Epub 2009 May 18.PMID: 19451446 [PubMed - indexed for MEDLINE]Related articles

    9.

    Sentinel node biopsy and standard of care for melanoma.

    Balch CM, Morton DL, Gershenwald JE, McMasters KM, Nieweg OE, Powell B, Ross MI, Sondak VK, Thompson JF.

    J Am Acad Dermatol. 2009 May;60(5):872-5.PMID: 19389531 [PubMed - indexed for MEDLINE]Related articles

    10.

    Age-related lymphatic dysfunction in melanoma patients.

    Conway WC, Faries MB, Nicholl MB, Terando AM, Glass EC, Sim M, Morton DL.

    Ann Surg Oncol. 2009 Jun;16(6):1548-52. Epub 2009 Mar 11.PMID: 19277787 [PubMed - indexed for MEDLINE]Related articles

    11.

    mRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanoma-associated antigen-specific monoclonal antibody beads.

    Kitago M, Koyanagi K, Nakamura T, Goto Y, Faries M, O'Day SJ, Morton DL, Ferrone S, Hoon DS.

    Clin Chem. 2009 Apr;55(4):757-64. Epub 2009 Feb 20.PMID: 19233913 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    CpG island methylator phenotype predicts progression of malignant melanoma.

    Tanemura A, Terando AM, Sim MS, van Hoesel AQ, de Maat MF, Morton DL, Hoon DS.

    Clin Cancer Res. 2009 Mar 1;15(5):1801-7. Epub 2009 Feb 17.PMID: 19223509 [PubMed - indexed for MEDLINE]Related articles

    13.

    Solitary dermal melanoma: beginning or end of the metastatic process?

    Lee CC, Faries MB, Ye X, Morton DL.

    Ann Surg Oncol. 2009 Mar;16(3):578-84. Epub 2009 Jan 6.PMID: 19130137 [PubMed - indexed for MEDLINE]Related articles

    14.

    Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors.

    Goto Y, Arigami T, Kitago M, Nguyen SL, Narita N, Ferrone S, Morton DL, Irie RF, Hoon DS.

    Mol Cancer Ther. 2008 Nov;7(11):3642-53.PMID: 19001446 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Importance of sentinel lymph node biopsy in patients with thin melanoma.

    Wright BE, Scheri RP, Ye X, Faries MB, Turner RR, Essner R, Morton DL.

    Arch Surg. 2008 Sep;143(9):892-9; discussion 899-900.PMID: 18794428 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The rationale for sentinel-node biopsy in primary melanoma.

    Morton DL, Cochran AJ, Thompson JF.

    Nat Clin Pract Oncol. 2008 Sep;5(9):510-1. No abstract available. PMID: 18679393 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Human high molecular weight-melanoma-associated antigen: utility for detection of metastatic melanoma in sentinel lymph nodes.

    Goto Y, Ferrone S, Arigami T, Kitago M, Tanemura A, Sunami E, Nguyen SL, Turner RR, Morton DL, Hoon DS.

    Clin Cancer Res. 2008 Jun 1;14(11):3401-7.PMID: 18519770 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Sentinel node biopsy: facts to clear the alleged clouds.

    Morton DL, Elashoff R.

    Arch Dermatol. 2008 May;144(5):685-6; author reply 687. No abstract available. PMID: 18490604 [PubMed - indexed for MEDLINE]Related articles

    19.

    Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine.

    Amersi FF, Terando AM, Goto Y, Scolyer RA, Thompson JF, Tran AN, Faries MB, Morton DL, Hoon DS.

    Clin Cancer Res. 2008 Feb 1;14(3):638-45. Erratum in: Clin Cancer Res. 2008 Mar 1;14(5):1598. Clin Cancer Res. 2008 May 1;14(9):2892. PMID: 18245522 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma.

    Lee CC, Faries MB, Wanek LA, Morton DL.

    J Clin Oncol. 2008 Feb 1;26(4):535-41.PMID: 18235114 [PubMed - indexed for MEDLINE]Related articles

    21.

    Surgery and sentinel lymph node biopsy.

    Faries MB, Morton DL.

    Semin Oncol. 2007 Dec;34(6):498-508. Review.PMID: 18083373 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Monocyte-derived IL-10 expression predicts prognosis of stage IV melanoma patients.

    Torisu-Itakura H, Lee JH, Huynh Y, Ye X, Essner R, Morton DL.

    J Immunother. 2007 Nov-Dec;30(8):831-8.PMID: 18049335 [PubMed - indexed for MEDLINE]Related articles

    23.

    The role of sentinel lymph node biopsy in the management of melanoma.

    Amersi F, Morton DL.

    Adv Surg. 2007;41:241-56. Review.PMID: 17972569 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial.

    Bilchik AJ, Hoon DS, Saha S, Turner RR, Wiese D, DiNome M, Koyanagi K, McCarter M, Shen P, Iddings D, Chen SL, Gonzalez M, Elashoff D, Morton DL.

    Ann Surg. 2007 Oct;246(4):568-75; discussion 575-7.PMID: 17893493 [PubMed - indexed for MEDLINE]Related articles

    25.

    Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma.

    Scheri RP, Essner R, Turner RR, Ye X, Morton DL.

    Ann Surg Oncol. 2007 Oct;14(10):2861-6. Epub 2007 Jul 18.PMID: 17882497 [PubMed - indexed for MEDLINE]Related articles

    26.

    In honor of Alfred Schutt Ketcham, M.D.

    Morton DL.

    J Surg Oncol. 2007 Sep 15;96(4):283-4. No abstract available. PMID: 17879336 [PubMed - indexed for MEDLINE]Related articles

    27.

    Significance of endogenous augmentation of antiganglioside IgM in cancer patients: potential tool for early detection and management of cancer therapy.

    Ravindranath MH, Muthugounder S, Hannah MR, Morton DL.

    Ann N Y Acad Sci. 2007 Jun;1107:212-22.PMID: 17804549 [PubMed - indexed for MEDLINE]Related articles

    28.

    A Comparison of 3 tumor markers (MIA, TA90IC, S100B) in stage III melanoma patients.

    Faries MB, Gupta RK, Ye X, Lee C, Yee R, Leopoldo Z, Essner R, Foshag LJ, Elashoff D, Morton DL.

    Cancer Invest. 2007 Aug;25(5):285-93.PMID: 17661202 [PubMed - indexed for MEDLINE]Related articles

    29.

    Vaccine therapy for melanoma: current status and future directions.

    Terando AM, Faries MB, Morton DL.

    Vaccine. 2007 Sep 27;25 Suppl 2:B4-16. Epub 2007 Jul 5. Review.PMID: 17646038 [PubMed - indexed for MEDLINE]Related articles

    30.

    Can completion lymph node dissection be avoided for a positive sentinel node in melanoma?

    Morton DL, Scheri RP, Balch CM.

    Ann Surg Oncol. 2007 Sep;14(9):2437-9. Epub 2007 Jun 17. No abstract available. PMID: 17574500 [PubMed - indexed for MEDLINE]Related articles

    31.

    Molecular characterization of inflammatory genes in sentinel and nonsentinel nodes in melanoma.

    Torisu-Itakura H, Lee JH, Scheri RP, Huynh Y, Ye X, Essner R, Morton DL.

    Clin Cancer Res. 2007 Jun 1;13(11):3125-32.PMID: 17545514 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Authors' response to a letter to the editor re: Sentinel node biopsy for early-stage melanoma.

    Morton DL, Cochran AJ, Thompson JF.

    Ann Surg. 2007 May;245(5):828-9. No abstract available. PMID: 17457182 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Glycoimmunomics of human cancer: current concepts and future perspectives.

    Ravindranath MH, Yesowitch P, Sumobay C, Morton DL.

    Future Oncol. 2007 Apr;3(2):201-14. Review.PMID: 17381420 [PubMed - indexed for MEDLINE]Related articles

    34.

    Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes.

    Zogakis TG, Essner R, Wang HJ, Foshag LJ, Morton DL.

    Ann Surg Oncol. 2007 May;14(5):1604-11. Epub 2007 Mar 1.PMID: 17333418 [PubMed - indexed for MEDLINE]Related articles

    35.

    Immunogenic gangliosides in human ovarian carcinoma.

    Ravindranath MH, Muthugounder S, Presser N, Selvan SR, Santin AD, Bellone S, Saravanan TS, Morton DL.

    Biochem Biophys Res Commun. 2007 Feb 9;353(2):251-8. Epub 2006 Dec 14. Erratum in: Biochem Biophys Res Commun. 2008 Dec 26;377(4):1331. PMID: 17188646 [PubMed - indexed for MEDLINE]Related articles

    36.

    Sentinel-node biopsy or nodal observation in melanoma.

    Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Glass EC, Wang HJ; MSLT Group.

    N Engl J Med. 2006 Sep 28;355(13):1307-17. Erratum in: N Engl J Med. 2006 Nov 2;355(18):1944. PMID: 17005948 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.

    Essner R, Scheri R, Kavanagh M, Torisu-Itakura H, Wanek LA, Morton DL.

    Arch Surg. 2006 Sep;141(9):877-82; discussion 882-4.PMID: 16983031 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Estrogen receptor-alpha methylation predicts melanoma progression.

    Mori T, Martinez SR, O'Day SJ, Morton DL, Umetani N, Kitago M, Tanemura A, Nguyen SL, Tran AN, Wang HJ, Hoon DS.

    Cancer Res. 2006 Jul 1;66(13):6692-8.PMID: 16818643 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Can surgical therapy alone achieve long-term cure of melanoma metastatic to regional nodes?

    Young SE, Martinez SR, Faries MB, Essner R, Wanek LA, Morton DL.

    Cancer J. 2006 May-Jun;12(3):207-11.PMID: 16803679 [PubMed - indexed for MEDLINE]Related articles

    40.

    Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome.

    Kim J, Mori T, Chen SL, Amersi FF, Martinez SR, Kuo C, Turner RR, Ye X, Bilchik AJ, Morton DL, Hoon DS.

    Ann Surg. 2006 Jul;244(1):113-20.PMID: 16794396 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Prospective multicenter trial of staging adequacy in colon cancer: preliminary results.

    Bilchik AJ, DiNome M, Saha S, Turner RR, Wiese D, McCarter M, Hoon DS, Morton DL.

    Arch Surg. 2006 Jun;141(6):527-33; discussion 533-4.PMID: 16785352 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.

    Shu S, Cochran AJ, Huang RR, Morton DL, Maecker HT.

    Cancer Metastasis Rev. 2006 Jun;25(2):233-42. Review.PMID: 16770535 [PubMed - indexed for MEDLINE]Related articles

    43.

    Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study.

    Wong SL, Morton DL, Thompson JF, Gershenwald JE, Leong SP, Reintgen DS, Gutman H, Sabel MS, Carlson GW, McMasters KM, Tyler DS, Goydos JS, Eggermont AM, Nieweg OE, Cosimi AB, Riker AI, G Coit D.

    Ann Surg Oncol. 2006 Jun;13(6):809-16. Epub 2006 Apr 12.PMID: 16604476 [PubMed - indexed for MEDLINE]Related articles

    44.

    The promise of metastasectomy in melanoma.

    Faries MB, Morton DL.

    Ann Surg Oncol. 2006 May;13(5):607-9. Epub 2006 Mar 13. No abstract available. PMID: 16538408 [PubMed - indexed for MEDLINE]Related articles

    45.

    Detection of clinically relevant melanoma metastases requires focused, not exhaustive, evaluation of sentinel lymph nodes.

    Cochran AJ, Morton DL.

    Am J Surg Pathol. 2006 Mar;30(3):419-20; author reply 420-1. No abstract available. PMID: 16538068 [PubMed - indexed for MEDLINE]Related articles

    46.

    Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients.

    Koyanagi K, O'Day SJ, Gonzalez R, Lewis K, Robinson WA, Amatruda TT, Kuo C, Wang HJ, Milford R, Morton DL, Hoon DS.

    Clin Cancer Res. 2006 Feb 15;12(4):1137-43.PMID: 16489066 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Melanoma recurrence patterns after negative sentinel lymphadenectomy.

    Zogakis TG, Essner R, Wang HJ, Turner RR, Takasumi YT, Gaffney RL, Lee JH, Morton DL.

    Arch Surg. 2005 Sep;140(9):865-71; discussion 871-2.PMID: 16172295 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Immunotherapy today: the story of a vaccine.

    Morton DL.

    J Drugs Dermatol. 2005 Sep-Oct;4(5):672-6. Review. No abstract available. PMID: 16167428 [PubMed - indexed for MEDLINE]Related articles

    49.

    Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial.

    Morton DL, Cochran AJ, Thompson JF, Elashoff R, Essner R, Glass EC, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Wang HJ; Multicenter Selective Lymphadenectomy Trial Group.

    Ann Surg. 2005 Sep;242(3):302-11; discussion 311-3.PMID: 16135917 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Therapeutic vaccines for melanoma: current status.

    Faries MB, Morton DL.

    BioDrugs. 2005;19(4):247-60. Review.PMID: 16128607 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...